BNF 73 march 2017 pdf

BNF 73 (March 2017) is the authoritative guide to prescribing, dispensing and administering medicines for all healthcare professionals.  Access to the latest edition of BNF is vital for healthcare professionals.

Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, this essential reference provides up-to-date guidance on prescribing, dispensing, and administering medicines.

Not only does the BNF include a widely accepted framework for the drug management of common diseases, it also includes details of medicines prescribed in the UK, with special reference to their uses, cautions, contraindications, side-effects and dosage. This allows treatment to be tailored to the individual needs of each patient.

The BNF is updated in print every six months by an expert team of pharmacists; validated by a network of leading clinicians from many spheres of clinical practice; and published under the authority of a Joint Formulary Committee. The BNF reflects current best practice as well as legal and professional guidelines relating to the use of medicines. As a result it is used widely as a touchstone reference, and cited by regulatory bodies and courts as a source of authority.

New content and updates:
 Updated guidance for conditions including anal fissure, coeliac disease, dementia, exocrine pancreatic insufficiency, food allergy, multiple sclerosis and short bowel syndrome. New prescribing guidance for biological and biosimilar medicines.
 New drug monographs alirocumab, blinatumomab, brivaracetam, ceftobiprole, clevidipine, elvitegravir, isavuconazole, nivolumab and panobinostat.
 New safety information about fire risk with paraffin-based skin emollients on dressings and clothing and advice on minimising the risk of infections when being treated with idelalisib.
 Updated guidance on starting routine for oral progestogen-only contraceptives and the use of sodium glucose co-transporter 2 inhibitors as monotherapy for treating type 2 diabetes.

Download link:

mediafire

BNF Publication 2.0 for android

BNF Publications have developed an app that gives up-to-date offline reference to the British National Formulary (BNF) and the British National Formulary for Children (BNFC). Aimed at UK NHS healthcare professionals involved with prescribing, monitoring, supplying and administering medicines; the app provides essential information on the selection of safe and effective medicines for individual patients.

Please read the app Terms and Conditions [http://www.bnf.org/products/bnfbnfcapp/bnf-bnf-app-terms-and-conditions/] carefully before using this mobile application. Downloading the app will indicate your acceptance. If you do not agree to these Terms and Conditions, you may not use the app.

Features include:
· Offline browsing and searching of content of the BNF and BNFC
· The ability to switch between adult and child content
· Autocomplete search with navigation panes for treatment summaries, drug monographs and medicinal products
· Powerful interactions checker
· Clinical content updated every month
· Update notifications when a new update is available
· Optimised for smart phones and tablets

Download:
Mediafire

bnf for children sept 2016-2017

This Medical Association and Royal Pharmaceutical Society of Great Britain app-book for BNFCis developed by Medhand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using Medhands patented technology.

Functions include:

• A powerful search
• Bookmarks, History and Highlighting
• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
• Notes and picture notes

The BNF for Children (BNFC) 2016-2017 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children.

Recommendations have been constructed on the basis of authoritative sources, emerging evidence and best practice guidelines. The content has been carefully validated by a network of paediatric experts and the process is overseen by a paediatric formulary committee.

The BNF for Children 2016-2017 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice.

Significant content updates include:

• New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid
• Updated guidance for conditions including asthma and obesity
• Updated pregnancy-prevention advice for patients taking mycophenolate mofetil
• New drug monographs including cholic acid
• New indications for adalimumab including chronic plaque psoriasis
• New safety information about the risk of osteonecrosis of the external auditory canal with bisphosphonates
• Guidance on suspected or confirmed drug allergies
• Evidence grading of BNF recommendations.

Unique benefits

• Shares the structure of the British National Formulary (BNF) and is designed to be used in paediatric and general practice settings
• Includes information on unlicensed use of medicines and provides details of unlicensed medicines that can be imported, manufactured by ‘special order' or prepared extemporaneously
• Covers the drug treatment of rare childhood conditions, provides guidance on specialist paediatric interventions and includes details of those medicines that are used in children in a different way to adults

International relevance

BNF and BNFC are the gold standard of drug information in English-speaking countries. They are used for constructing national formularies in other countries and to support regulatory work. They provide essential information when treating patients who have been prescribed medicines in the UK. Unlike many other local alternatives, both resources are completely independent from pharmaceutical industry influence with guidance that is based on best practice and real life evidence.

Published jointly by the British Medical Association, Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group.

________________________________________

MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade. Offering most trusted and well recognized medical guidelines provided by excellent publishers like Pharmaceutical Press, Oxford University Press, McGraw-Hill, Elsevier, Wiley and more.


Download link:
Mediafire

BNF 73 march-sept 2017

This Medical Association and Royal Pharmaceutical Society of Great Britain app-book, British National Formulary (BNF) 73, is developed by Medhand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using Medhands patented technology.

Important: This is a downloaded, offline app. The application is a single edition only; to stay updated it is recommended to purchase the forthcoming editions as they are revised twice yearly.

Functions include:

• A powerful search
• Bookmarks, History and Highlighting
• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
• Notes and picture notes

Compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide, the new edition of the British National Formulary 73 (BNF) provides up-to-date guidance on prescribing, dispensing, and administering medicines. Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.

NICE has accredited the editorial process used by the British National Formulary to produce its resources.*

New content updates in the BNF 73 include:

• Updated guidance for conditions including anal fissure, coeliac disease, dementia, exocrine pancreatic insufficiency, food allergy, multiple sclerosis and short bowel syndrome. New prescribing guidance for biological and biosimilar medicines.
• New drug monographs alirocumab, blinatumomab, brivaracetam, ceftobiprole, clevidipine, elvitegravir, isavuconazole, nivolumab and panobinostat.
• New safety information about fire risk with paraffin-based skin emollients on dressings and clothing and advice on minimising the risk of infections when being treated with idelalisib.
• Updated guidance on starting routine for oral progestogen-only contraceptives and the use of sodium glucose co-transporter 2 inhibitors as monotherapy for treating type 2 diabetes.

Improvements in the new edition:

Since the launch of the new format BNF we have actively sought your comments and feedback, and as a result have made the following improvements to this edition:

• Important safety information is displayed prominently within the monograph
• Class monographs (e.g. ACE inhibitors) are easy to navigate to from the individual monographs.

The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee.


Authors: Joint Formulary Committee
________________________________________

MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade. Offering most trusted and well recognized medical guidelines provided by excellent publishers like Pharmaceutical Press, Oxford University Press, McGraw-Hill, Wiley, Elsevier and more.

Download link:
Mediafire

new BNF and BNFC apps

About the new BNF & BNFC App
The BNF & BNFC App has been developed for NHS UK healthcare professionals by the publishers of the BNF. Its fast, intuitive searching and easy-to-use design gives you access to practical, evidence-based medicines information whenever – and wherever – you need it.

BNF and BNF for Children content in a single App – simple switching between publications

Purpose-built for iOS and Android platforms

Clinical content updated every month.

Information arranged into clear sections, matching the print and online BNF – Drugs, Treatment summaries, Interactions, Medical devices, Borderline substances and Wound care Speedy, intuitive, predictive search.

An interactions checker makes it easy to identify issues between combinations of drugs

Download from the App Store and Google Play

Help with using the App
Here are some of the most common questions we’ve been asked. If you can’t find the answer to your query please see our full FAQs.
Who is the App aimed at?

The BNF & BNFC App is aimed at prescribers, pharmacists, and other healthcare professionals who need sound, up-to-date information about the use of medicines. The App contains all of the content from BNF and BNFC in one place, ensuring easy access to BNF information wherever you are.

How do I find and download the App?
The App can be downloaded from the App Store for iOS devices, and Google Play for Android devices.

Do I still need my Athens authentication to access the App?
No, the new App can be accessed without an Athens password.


Android apk download link:
Dropbox

DrugDoses v5.5 (Frank Shann)

Requirements: Varies with device
Overview: For more than 25 years, Frank Shann’s little booklet has helped physicians all around the world prescribe drugs to children. DrugDoses now contains more than 2050 entries. It lists every drug commonly prescribed for systemic use in both adults and children.

The Android version of the booklet gives you an enormous amount of information, which will be updated twice a year!
You will therefore always have the latest drugs, which will only be available in the paper version in a year or two!
We offer you the initial 2-year license, with all the updates.
After that period, as you will need to keep the drugs database updated, we offer you the possibility to purchase a lifetime license for only 5$!
The Android version has also lots of other features: more than 150 current laboratory values, a useful cardiology database and a calculator that will help you give the correct resuscitation doses when you are coding a child.

DrugDoses also integrates PedCalc. It contains the most common pediatric scores and formulas :

- ASA score
- Alveolo-arterial gradient
- Anion gap
- Apgar score
- Blunt abdominal trauma score
- Body mass index
- Body surface area
- Corrected Ca*
- Creatinine clearance - measured
- Creatinine clearance - estimated
- Drip rate
- Endotracheal tube sizes
- FeNa
- Genta dosing*
- Glasgow Coma Score
- Glasgow Outcome Scale
- Heparin dosage*
- Maintenance fluids
- Mallampati
- NACA score
- Neonatal central lines
- Oxygen index
- PaO2/FiO2 ratio*
- Parkland formula*
- Pediatric trauma score
- Predicted height
- Predicted spirometry values
- QTc
- Tubular phosphate reabsorption
- Vanco dosing*
* These calculations are available via an In-App bundle

We have also integrated Frank Shann's Pediatric Critical Care Guidelines.
The booklet contains all the latest guidelines available for pediatric critical care.
Our new feature contains all the 67 chapters of the booklet, ranging from Analgesia & Sedation to Ventilation.
PICU Guidelines is fully searchable, and will save your personal notes, as well as give you the possibility to send them to colleagues.
PICU Guidelines is available via an InApp purchase.
Once you've bought it, you'll be give free access to all future updates of this great reference.
However, if you already have the separate app, it will unfortunately not entitle you to get this in-app version.
By the way, did you know that by becoming a fan of DrugDoses on Facebook ( http://facebook.drugdoses.net ), you can directly request new features and get information on the updates and changes in the database?



In-App Purchases :

• When you purchase DrugDoses, you will get a complimentary 2-year license. Thereafter, you will have to purchase a lifetime license.
• There are also some extra PedCalc features that can be bought as a bunddle, also using In-App purchase. There is no subscription to these extra features, so you will only have to buy them once.
• PICU Guidelines can also be bought as an In-App purchase. There is no subscription to this extra feature, so you will only have to buy it once.
• Payment will be charged to your Google Play Account at confirmation of purchase.
• Our Privacy Policy is available on our website : http://www.drugdoses.net/privacy 

New update, with:
Updated the database, with the latest drugs from Frank Shann's 17th edition!

NOTE : In-Apps not UNLOCKED. If you want unlock use FREEDOM.

This app has NO advertisements

Download link:
Mediafire

british national formulary 70 pdf version

The BNF provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. This essential reference reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.



BNF 70 (September 2015) has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next.To make it even easier to find the information you need, the content in the new BNF 70 has been restructured. You’ll find improved consistency and clarity in the print version.

Some of the significant content updates in this edition include:

• New safety information about reducing the risk of QT interval prolongation and Torsade de Pointes with hydroxyzine• New advice about the risk of lymphopenia and potential risk of progressive multifocal leukoencephalopathy with dimethyl fumarate• Further guidance on the restricted use of codeine for the treatment of cough and cold symptoms in children• Addition of new indications for omalizumab for treating chronic spontaneous urticaria and for lenalidomide in certain patients with multiple myeloma• Updated dosing information for the use of tramadol in the treatment of acute and chronic pain• Guidance about dose reduction for lisdexamfetaminemesilate for patients with severe renal impairment• Updated contra-indications for aceclofenac in patients with certain established cardiovascular diseases• Addition of new preparations, including DuoRespSpiromax® (budesonide with formoterol), Envarsus® (tacrolimus), FostairNEXThaler® (beclometasone with formoterol), Jaydess® (levonorgestrel), Ketoconazole HRA® (ketoconazole) and Lonquex® (lipegfilgrastim)
The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee. 



Download link
Mediafire